IWFS:LSE:LSE-iShares MSCI World Size Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 3374.5

Change

0.00 (0.00)%

Market Cap

USD 0.23B

Volume

2.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.25 (+2.21%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.04 (-0.03%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 547.46B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.89%)

USD 547.46B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.70 (-0.97%)

USD 266.08B
0QZO:LSE 0QZO

+0.50 (+0.54%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.81 (-1.07%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.20 (-0.64%)

USD 200.79B
0R24:LSE Intel Corp.

+0.65 (+2.93%)

USD 196.14B

ETFs Containing IWFS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.18% 35% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.18% 32% F 41% F
Trailing 12 Months  
Capital Gain 7.62% 52% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.62% 50% F 57% F
Trailing 5 Years  
Capital Gain 28.87% 53% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.87% 50% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.66% 58% F 63% D
Dividend Return 6.66% 57% F 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.79% 56% F 71% C-
Risk Adjusted Return 52.09% 65% D 77% C+
Market Capitalization 0.23B 58% F 43% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike